Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

6,020 total articles

DURAVYU Durability: A Phase-3 Data Bet with Asymmetric Upside for EYPT

DURAVYU Durability: A Phase-3 Data Bet with Asymmetric Upside for EYPT

EyePoint (EYPT) is priced like a development-stage story despite a large market cap and thin revenue. DURAVYU's sustained-release profile and upcoming Phase 3 topline readout for wet AMD in mid-2026 create a clear catalyst. This trade idea outlines an actionable long with entry, stop, and target, and discusses the balance between clinical binary ri…

Microsoft: Buy the AI-Driven Dip — High-Conviction Trade Setup

Microsoft: Buy the AI-Driven Dip — High-Conviction Trade Setup

Microsoft ($MSFT) is a table-pounding buy here. The business sits at the center of the AI infrastructure wave (Azure + exclusive OpenAI licensing), generates huge free cash flow ($72.9B last reported), and trades at a reasonable P/E (~24x) relative to durable growth and margin profile. This trade plan buys $405.08 with a $365 stop and a $500 target…

Diageo Poised for a Re-rating Under 'Drastic Dave' - A Long Trade Plan

Diageo Poised for a Re-rating Under 'Drastic Dave' - A Long Trade Plan

Diageo's stock has been punished after weak H1 results, an organic sales decline and a deep dividend cut. At $80.69 the market prices a company with a $45B market cap at roughly mid-cycle multiples; new CEO David John Lewis - nicknamed 'Drastic Dave' by the market - has signaled hard cost moves and asset-shedding that could drive margin recovery an…

Buy the Dip in On Holding: Ride Asia Rebound and Strong Apparel Momentum

Buy the Dip in On Holding: Ride Asia Rebound and Strong Apparel Momentum

On Holding (ONON) posted solid Q1 results and raised EBITDA guidance, with revenue +14.5% YoY (26.4% FXN) and margin expansion. Asia is reaccelerating and apparel is contributing meaningful upside. Technicals are constructive around the $33-$36 range and short interest has been material but manageable. I recommend a buy at $35.40 with a $31.50 stop…

RELX: Oversold, Cash-Generating Info-Analytics - Upgrade to Buy

RELX: Oversold, Cash-Generating Info-Analytics - Upgrade to Buy

RELX is trading nearer its 52-week low with a 2.64% yield and a P/E of 22. With recurring information-and-analytics cash flows, recent enterprise wins for LexisNexis products, and an improving UK macro backdrop, the risk/reward now favors taking a position. Technicals are oversold, presenting a tactical entry for a long-term trade aimed at capitali…

AppLovin: A High-Conviction Add on the Pullback

AppLovin: A High-Conviction Add on the Pullback

AppLovin (APP) tumbled intraday but the underlying business metrics - Q1 revenue growth north of 50%, stretched but improving margins, and a still-robust ad-monetization platform - argue for adding to longs here. This trade idea lays out a concrete entry at the current level, a defensive stop, and a target tied to prior highs with a long-term horiz…

Intel: Fade the Momentum — Trade the Apple-Led Spike, Don’t Marry It

Intel: Fade the Momentum — Trade the Apple-Led Spike, Don’t Marry It

Intel has been pulled sharply higher by a sector-wide AI and tech rally. Fundamentals still lag the market’s enthusiasm: negative EPS, negative free cash flow, and stretched multiples vs. underlying profits. Technicals show overbought conditions and heavy options-driven flow. This idea outlines a mid-term short (45 trading days) with an exact entry…

Caterpillar Is Critical To AI Power Buildouts - But I Prefer Shorting the Stock and Buying Its Laggard Rivals

Caterpillar Is Critical To AI Power Buildouts - But I Prefer Shorting the Stock and Buying Its Laggard Rivals

Caterpillar is benefiting from a surge in data-center and power infrastructure demand tied to AI, but lofty valuation (P/E ~45, EV/EBITDA ~31), high leverage, and a strong recent run-up make CAT a risky name to own here. I prefer strategically shorting CAT over a mid-term horizon while rotating capital into select smaller-exposure rivals that trade…

Replimune Bounce Trade: Betting on RP1's Second Act After an FDA Setback

Replimune Bounce Trade: Betting on RP1's Second Act After an FDA Setback

Replimune (REPL) cratered after an FDA Complete Response Letter for RP1 on 04/10/2026. The stock now trades at $5.295 with heavy volume and stretched short interest. This trade idea outlines a tactical long - entry $5.30, stop $3.90, target $9.00 - sized as a high-risk swing position that plays for a regulatory re-opening, renewed investor focus, o…